Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Entero Healthcare SolutionsBOM:544122 +0.79%67 EBITDA Margin % is 5.15% as of Jun. 2026, which is 103% above its 10-year median of 2.54. GuruFocus rates BOM:544122 with a GF Score™ of 67/100 and a GF Value™ of ₹1,739.96 (Modestly Undervalued). The stock has 5 warning signs investors should review. Among 119 Medical Distribution companies, Entero Healthcare Solutions ranks better than 51.26% on this metric.
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Entero Healthcare Solutions EBITDA Margin % Related Terms
Entero Healthcare Solutions EBITDA Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:544122 vs MCK, COR, CAH: EBITDA Margin % Comparison
For the Medical Distribution subindustry, Entero Healthcare Solutions's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Entero Healthcare Solutions EBITDA Margin % vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Entero Healthcare Solutions's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Entero Healthcare Solutions's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Entero Healthcare Solutions (BOM:544122) has a EBITDA Margin % of 5.15% as of Jun. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Entero Healthcare Solutions and its competitors. This is 103% above median its historical median of 2.54. Over the past decade, Entero Healthcare Solutions' EBITDA Margin % has ranged from 1.04 to 4.51. According to the industry distribution chart, Entero Healthcare Solutions ranks #58 out of 119 companies in the Medical Distribution industry, placing it in the top 48.7%.
Is Entero Healthcare Solutions' EBITDA Margin % too high?
Entero Healthcare Solutions' current EBITDA Margin % of 5.15% is 103% above median its 10-year median of 2.54. Over the past 10 years, this metric has ranged from a low of 1.04 to a high of 4.51. The Medical Distribution industry median EBITDA Margin % is 4.31. Entero Healthcare Solutions' value of 5.15% is 19.5% above this industry median. Based on the distribution chart, Entero Healthcare Solutions ranks #58 out of 119 companies in the Medical Distribution industry, which is above the industry midpoint. Overall, Entero Healthcare Solutions has a GF Score™ of 67/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Entero Healthcare Solutions' EBITDA Margin % compare to MCK and COR?
According to the Medical Distribution industry distribution chart, Entero Healthcare Solutions ranks #58 out of 119 companies for EBITDA Margin %. This puts Entero Healthcare Solutions in the upper half of its industry. The industry median EBITDA Margin % is 4.31. Entero Healthcare Solutions' value of 5.15% is 19.5% above this benchmark. Historically, Entero Healthcare Solutions' own EBITDA Margin % has ranged from 1.04 to 4.51 over the past decade. While the company's 10-year median is 2.54 vs. the industry median of 4.31, Entero Healthcare Solutions has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Medical Distribution company?
The median EBITDA Margin % among Medical Distribution companies is 4.31, based on 119 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Entero Healthcare Solutions's current EBITDA Margin % of 5.15% is 19.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Entero Healthcare Solutions and its competitors. For the Medical Distribution industry, the median EBITDA Margin % is 4.31 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Entero Healthcare Solutions's current EBITDA Margin % is 5.15%, which is 103% above median its own 10-year median of 2.54. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Entero Healthcare Solutions stock overvalued right now?
Based on GuruFocus' analysis, Entero Healthcare Solutions (BOM:544122) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹1,739.96, compared to a current price of ₹1,420.30 — trading 18.4% below its estimated fair value. The current EBITDA Margin % is 5.15%, which is 103% above median its 10-year median of 2.54 and 19.5% above the Medical Distribution industry median of 4.31. Entero Healthcare Solutions' overall GF Score™ is 67/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Entero Healthcare Solutions (BOM:544122), the current EBITDA Margin % is 5.15% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Entero Healthcare Solutions (BOM:544122) Overvalued in 2026?
Based on GuruFocus' analysis, Entero Healthcare Solutions stock appears to be undervalued.
The current stock price of ₹1,420.30 is trading 18.4% below its estimated GF Value™ of ₹1,739.96.
GuruFocus considers Entero Healthcare Solutions to be Modestly Undervalued.
Key valuation signals for BOM:544122:
EBITDA Margin %: 5.15% (103% above median its 10-year median of 2.54)
GF Value™: ₹1,739.96 vs. price of ₹1,420.30 (18.4% below fair value)
Industry Position: 19.5% above the Medical Distribution median (#58 of 119)
No single metric tells the full story. See the BOM:544122 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Entero Healthcare Solutions Ltd is a healthcare products distributor in India. It is involved in the business of distribution and marketing of pharmaceutical and surgical products and allied services. Geographically, the company derives a majority of its revenue from the domestic market.
67GF Score
Get the complete analysis for BOM:544122
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:544122 has been successfully added to your 
